No black box warning on record for Clindamycin Phosphate And Tretinoin Gel 1.2%/0.025%

As of the latest FDA labeling reviewed, Clindamycin Phosphate And Tretinoin Gel 1.2%/0.025% (CLINDAMYCIN PHOSPHATE AND TRETINOIN GEL 1.2%/0.025%) does not carry a black box warning. Standard warnings and precautions still apply — see the full Clindamycin Phosphate And Tretinoin Gel 1.2%/0.025% medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Colitis: Clindamycin can cause severe colitis, which may result in death. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported with the use of clindamycin. Clindamycin phosphate and tretinoin gel should be discontinued if significant diarrhea occurs. (5.1) Ultraviolet Light and Environmental Exposure: Avoid exposure to sunlight,

No black box warning on record for Clindamycin Phosphate And Tretinoin Gel 1.2%/0.025%

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Colitis: Clindamycin can cause severe colitis, which may result in death. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported with the use of clindamycin. Clindamycin phosphate and tretinoin gel should be discontinued if significant diarrhea occurs. (5.1) Ultraviolet Light and Environmental Exposure: Avoid exposure to sunlight,

Clindamycin Phosphate And Tretinoin Gel 1.2%/0.025% Black Box Warning

No black box warning on record for Clindamycin Phosphate And Tretinoin Gel 1.2%/0.025%

Other warnings & precautions

Clindamycin Phosphate And Tretinoin Gel 1.2%/0.025% Black Box Warning

No black box warning on record for Clindamycin Phosphate And Tretinoin Gel 1.2%/0.025%

Other warnings & precautions